Therapy of Melanoma with Antigen-Specific T Cell Clones

Yee, Cassian

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 5R01CA071849-04
• Application #: 2895653
• Study Section: Special Emphasis Panel (SRC (12))
• Program Officer: Xie, Heng
• Project Start: 1996-07-01
• Project End: 2000-10-31
• Budget Start: 1999-05-01
• Budget End: 2000-10-31
• Support Year: 4
• Fiscal Year: 1999

Institution

• Name: Fred Hutchinson Cancer Research Center
• DUNS #: 075524595
• City: Seattle
• State: WA
• Country: United States
• Zip Code: 98109

Publications

Yee, C; Thompson, J A; Roche, P et al. (2000) Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J Exp Med 192:1637-44

Yee, C; Savage, P A; Lee, P P et al. (1999) Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J Immunol 162:2227-34

Yee, C; Riddell, S R; Greenberg, P D (1997) Prospects for adoptive T cell therapy. Curr Opin Immunol 9:702-8